Home › AmpliPhi Biosciences' CEO To Discuss Novel Approaches To Fighting Drug-Resistant Pathogens In Panel At BIO International
 

Keywords :   


AmpliPhi Biosciences' CEO To Discuss Novel Approaches To Fighting Drug-Resistant Pathogens In Panel At BIO International

2016-06-01 05:37:22| drugdiscoveryonline Home Page

AmpliPhi Biosciences Corporation , a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, recently announced that M. Scott Salka, AmpliPhi’s Chief Executive Officer, will participate in a panel discussion at this year’s BIO International Convention

Tags: international panel discuss bio

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09This weeks lesson: Weaning matters in the cattle market
20.09Construction giant collapses putting 2,400 jobs at risk
20.09KANSAI HELIOS Further Expands as System Supplier in Italy
More »